大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/25 | 4,180 | 4,203 | 4,138 | 4,203 | +2 | ±0% | 790,900 |
| 2022/01/24 | 4,153 | 4,206 | 4,145 | 4,201 | +48 | +1.2% | 779,000 |
| 2022/01/21 | 4,123 | 4,170 | 4,101 | 4,153 | +23 | +0.6% | 569,700 |
| 2022/01/20 | 4,087 | 4,182 | 4,087 | 4,130 | +55 | +1.3% | 761,500 |
| 2022/01/19 | 4,109 | 4,130 | 4,057 | 4,075 | -56 | -1.4% | 856,700 |
| 2022/01/18 | 4,164 | 4,190 | 4,126 | 4,131 | -17 | -0.4% | 549,900 |
| 2022/01/17 | 4,119 | 4,178 | 4,113 | 4,148 | +62 | +1.5% | 668,800 |
| 2022/01/14 | 4,131 | 4,154 | 4,076 | 4,086 | -138 | -3.3% | 1,368,100 |
| 2022/01/13 | 4,241 | 4,253 | 4,202 | 4,224 | -48 | -1.1% | 898,100 |
| 2022/01/12 | 4,250 | 4,284 | 4,231 | 4,272 | +37 | +0.9% | 1,115,300 |
| 2022/01/11 | 4,284 | 4,333 | 4,195 | 4,235 | -13 | -0.3% | 1,283,200 |
| 2022/01/07 | 4,237 | 4,249 | 4,210 | 4,248 | +36 | +0.9% | 1,002,400 |
| 2022/01/06 | 4,260 | 4,266 | 4,192 | 4,212 | -27 | -0.6% | 791,800 |
| 2022/01/05 | 4,211 | 4,254 | 4,197 | 4,239 | +17 | +0.4% | 750,100 |
| 2022/01/04 | 4,184 | 4,230 | 4,171 | 4,222 | +53 | +1.3% | 887,100 |
| 2021/12/30 | 4,187 | 4,215 | 4,165 | 4,169 | -56 | -1.3% | 706,600 |
| 2021/12/29 | 4,238 | 4,251 | 4,205 | 4,225 | -74 | -1.7% | 605,500 |
| 2021/12/28 | 4,261 | 4,299 | 4,256 | 4,299 | +54 | +1.3% | 960,200 |
| 2021/12/27 | 4,270 | 4,272 | 4,233 | 4,245 | -39 | -0.9% | 711,500 |
| 2021/12/24 | 4,300 | 4,300 | 4,252 | 4,284 | +6 | +0.1% | 513,900 |
| 2021/12/23 | 4,263 | 4,278 | 4,241 | 4,278 | +11 | +0.3% | 486,100 |
| 2021/12/22 | 4,263 | 4,276 | 4,255 | 4,267 | +20 | +0.5% | 614,000 |
| 2021/12/21 | 4,274 | 4,283 | 4,232 | 4,247 | +43 | +1% | 673,500 |
| 2021/12/20 | 4,202 | 4,235 | 4,193 | 4,204 | -10 | -0.2% | 615,800 |
| 2021/12/17 | 4,232 | 4,278 | 4,214 | 4,214 | -62 | -1.4% | 1,385,800 |
| 2021/12/16 | 4,250 | 4,279 | 4,228 | 4,276 | +94 | +2.2% | 906,700 |
| 2021/12/15 | 4,173 | 4,204 | 4,158 | 4,182 | +16 | +0.4% | 746,400 |
| 2021/12/14 | 4,129 | 4,169 | 4,125 | 4,166 | +58 | +1.4% | 913,400 |
| 2021/12/13 | 4,140 | 4,155 | 4,103 | 4,108 | +14 | +0.3% | 656,400 |
| 2021/12/10 | 4,128 | 4,144 | 4,082 | 4,094 | -45 | -1.1% | 1,112,800 |
| 2021/12/09 | 4,177 | 4,194 | 4,138 | 4,139 | -35 | -0.8% | 799,600 |
| 2021/12/08 | 4,174 | 4,198 | 4,146 | 4,174 | +33 | +0.8% | 1,060,700 |
| 2021/12/07 | 4,100 | 4,164 | 4,047 | 4,141 | +91 | +2.2% | 1,244,700 |
| 2021/12/06 | 4,076 | 4,093 | 4,050 | 4,050 | -22 | -0.5% | 793,100 |
| 2021/12/03 | 4,046 | 4,083 | 4,012 | 4,072 | +36 | +0.9% | 1,055,300 |
| 2021/12/02 | 4,040 | 4,096 | 4,029 | 4,036 | -15 | -0.4% | 1,106,300 |
| 2021/12/01 | 4,051 | 4,121 | 4,040 | 4,051 | -95 | -2.3% | 1,915,600 |
| 2021/11/30 | 4,065 | 4,146 | 4,062 | 4,146 | +116 | +2.9% | 4,634,100 |
| 2021/11/29 | 4,043 | 4,080 | 4,017 | 4,030 | -59 | -1.4% | 1,714,400 |
| 2021/11/26 | 4,128 | 4,138 | 4,057 | 4,089 | -80 | -1.9% | 1,713,900 |
| 2021/11/25 | 4,141 | 4,180 | 4,111 | 4,169 | +25 | +0.6% | 1,086,200 |
| 2021/11/24 | 4,179 | 4,191 | 4,126 | 4,144 | -14 | -0.3% | 1,349,600 |
| 2021/11/22 | 4,091 | 4,172 | 4,088 | 4,158 | +42 | +1% | 1,363,700 |
| 2021/11/19 | 4,111 | 4,142 | 4,091 | 4,116 | -19 | -0.5% | 2,150,200 |
| 2021/11/18 | 4,155 | 4,168 | 4,116 | 4,135 | -55 | -1.3% | 1,186,400 |
| 2021/11/17 | 4,256 | 4,280 | 4,190 | 4,190 | -69 | -1.6% | 1,060,400 |
| 2021/11/16 | 4,271 | 4,320 | 4,257 | 4,259 | -10 | -0.2% | 1,099,800 |
| 2021/11/15 | 4,340 | 4,386 | 4,268 | 4,269 | -23 | -0.5% | 1,268,700 |
| 2021/11/12 | 4,401 | 4,456 | 4,268 | 4,292 | -103 | -2.3% | 2,153,100 |
| 2021/11/11 | 4,410 | 4,430 | 4,378 | 4,395 | -48 | -1.1% | 654,100 |
801～
850
件表示中 / 3518件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
